Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death

Journal of Neuroscience

Volumn 16, Issue 4, 1996, Pages 1337-1345

  Morrison, Richard S ^a   Wenzel, H Jurgen ^a   Kinoshita, Yoshito ^a   Robbins, Carol A ^a   Donehower, Larry A ^b   Schwartzkroin, Philip A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Brain injury; Epilepsy; Excitotoxin; Hippocampus; Neurons; p53

Indexed keywords

KAINIC ACID; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; EPILEPSY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DEATH; GENES, P53; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; KAINIC ACID; MICE; MICE, INBRED STRAINS;

EID: 0029915857     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-04-01337.1996     Document Type: Article

References (52)

1. Allsopp TE, Wyatt S, Paterson HF, Davies AM (1993) The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73:295-307.
2. Appel SH (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer's disease. Ann Neurol 10:499-505.
3. Behl C, Hovey L, Krajewski S, Schubert D, Reed JC (1993) Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem Biophys Res Commun 197:949-956.
4. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608.
5. Bristow RG, Jang A, Peacock J, Chung S, Benchimol S, Hill RP (1994) Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene 9:1527-1536.
6. Davies AM, Rosenthal A (1994) Neurons from mouse embryos with a null mutation in the tumour suppressor gene p53 undergo normal cell death in the absence of neurotrophins. Neurosci Lett 182:112-114.
7. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
8. Fisher DE (1994) Apoptosis in cancer therapy: crossing the threshold Cell 78:539-542.
9. Franck JE, Kunkel DD, Baskin DG, Schwartzkroin PA (1988) Inhibition in kainate-lesioned hyperexcitable hippocampi: physiologic, autoradiooraphic, and immunocytochemical observations. J Neurosci 8:1991-2002.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
11. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H (1994) Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71:219-225.
12. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
13. Halliwell B, Gutteridge JMC (1989) Free radicals in biology and medicine, 2nd Ed. Oxford: Clarendon.
14. Harvey M, McArthur MJ, Montgomery Jr CA, Butel JS, Bradley A, Donehower LA (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature Genet 5:225-229.
15. Heimer L (1970) Selective silver-impregnation of degenerating axoplasm. In: Contemporary research methods in neuroanatomy (Nauta WJH, Ebbesson SOE, eds), pp 106-131. Berlin: Springer.
16. Hockenbery DM, Oltvai ZN, Yin X, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
17. Ignatowicz E, Vezzani A-M, Rizzi M, D'Incalci M (1991) Nerve cell death induced in vivo by kainic acid and quinolinic acid does not involve apoptosis. NeuroReport 2:651-654.
18. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1-7.
19. Jayaraman L, Prives C (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81:1021-1029.
20. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Örd T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262:1274-1277.
21. Kasof GM, Mandelzys A, Maika SD, Hammer RE, Curran T, Morgan JI (1995) Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J Neurosci 15:4238-4249.
22. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708-1711.
23. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC (1994b) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323-1333.
24. Krajewski S, Krajewska M, Shabaik A, Wang HG, Irie S, Fong L, Reed JC (1994a) Immunohistochemical analysis of in vivo patterns of bcl-x expression. Cancer Res 54:5501-5507.
25. Lee S, Elenbaas B, Levine A, Griffith J (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013-1020.
26. 3H]kainic acid to receptor sites in rat brain. Mol Pharmacol 15:492-505.
27. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
28. Malkin D, Li F, Strong L, Fraumeni J, Nelson C, Kim D, Kassel J, Gryka M, Bischoff F, Tainsky M, Friend S (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.
29. Martinou J, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J (1994) Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030.
30. Merry DE, Veis DJ, Hickey W F, Korsmeyer SJ (1994) Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120:301-311.
31. Miyashita T, Reed JC (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
32. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1994a) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
33. Miyashita T, Harigai M, Hanada M, Reed JC (1994b) Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135.
34. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY (1995) Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506-1510.
35. Nadler JV, Perry BW, Cotman CW (1978) Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 271:676-677.
36. Nitatori T, Sato N, Waguri S, Karasawa Y, Araki H, Shibanai K, Kominami E, Uchiyama Y (1995) Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 15:1001-1011.
37. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619.
38. Portera-Cailliau C, Hedreen JC, Price DL, Koliatsos VE (1995) Evidence for apoptotic cell death in Huntington's disease and excitotoxic animal models. J Neurosci 15:3775-3787.
39. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SE, Salter DM, Bird CC Wyllie AH, Hooper ML, Clarke AR (1994) Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9:603-609.
40. Raff MC, Barres BA, Burne JF, Coles HS, Ishaizaki Y, Jacobson MD (1993) Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695-700.
41. Represa A, Tremblay E, Ben-Ari Y (1987) Kainate binding sites in the hippocampal mossy fibers: localization and plasticity. Neuroscience 20:739-748.
42. Sakhi S, Bruce A, Sun N, Tocco G, Baudry M, Schreiber SS (1994) p53 induction is associated with neuronal damage in the central nervous system. Proc Natl Acad Sci USA 91:7525-7529.
43. Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028-12032.
44. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J (1992) Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495-4499.
45. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747-749.
46. Strasser A, Harris AW, Jacks T, Cory S (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by bcl-2. Cell 79:329-339.
47. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711.
48. Tasker RAR, Connell BJ, Strain SM (1991) Pharmacology of systemically administered domoic acid in mice. Can J Physiol Pharmacol 69:378-382.
49. Timme T, Thompson TC (1994) Rapid allelotype analysis of p53 knockout mice. Biotechniques 17:461-463.
50. Vaux DL, Cory S, Adams JM (1988) Bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
51. Wood KA, Dipasquale B, Youle RJ (1993) In situ labeling of granule cells for apoptosis-associated DNA fragmentation reveals different mechanisms of cell loss in developing cerebellum. Neuron 11:621-632.
52. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:340-345.